These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26358933)

  • 1. Practice points in gynecardiology: Abnormal uterine bleeding in premenopausal women taking oral anticoagulant or antiplatelet therapy.
    Maas AH; Euler Mv; Bongers MY; Rolden HJ; Grutters JP; Ulrich L; Schenck-Gustafsson K
    Maturitas; 2015 Dec; 82(4):355-9. PubMed ID: 26358933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal uterine bleeding in anticoagulated patients by drug class: outcomes and management.
    Brioso XB; Bolt M; Sammel MD; McKenney K
    Am J Obstet Gynecol; 2023 Sep; 229(3):318.e1-318.e14. PubMed ID: 37201695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism.
    Godin R; Marcoux V; Tagalakis V
    Vascul Pharmacol; 2017 Aug; 93-95():1-5. PubMed ID: 28479313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series.
    Beyer-Westendorf J; Michalski F; Tittl L; Hauswald-Dörschel S; Marten S
    Lancet Haematol; 2016 Oct; 3(10):e480-e488. PubMed ID: 27692306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Committee opinion no. 606: Options for prevention and management of heavy menstrual bleeding in adolescent patients undergoing cancer treatment.
    Obstet Gynecol; 2014 Aug; 124(2 Pt 1):397-402. PubMed ID: 25050771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measured menstrual blood loss in women with a bleeding disorder or using oral anticoagulant therapy.
    van Eijkeren MA; Christiaens GC; Haspels AA; Sixma JJ
    Am J Obstet Gynecol; 1990 May; 162(5):1261-3. PubMed ID: 2339725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation.
    Huq FY; Tvarkova K; Arafa A; Kadir RA
    Contraception; 2011 Aug; 84(2):128-32. PubMed ID: 21757053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey.
    Klok FA; Schreiber K; Stach K; Ageno W; Middeldorp S; Eichinger S; Delluc A; Blondon M; Ay C
    Thromb Res; 2017 May; 153():101-107. PubMed ID: 28376343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management of abnormal uterine bleeding in premenopausal women.
    Sweet MG; Schmidt-Dalton TA; Weiss PM; Madsen KP
    Am Fam Physician; 2012 Jan; 85(1):35-43. PubMed ID: 22230306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medical management of abnormal uterine bleeding in reproductive-aged women.
    Bradley LD; Gueye NA
    Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Office hysteroscopy safety and feasibility in women receiving anticoagulation and anti-platelet treatment.
    Tsampras N; Ma K; Arora R; McLeod G; Minchelotti F; Craciunas L
    Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():110-113. PubMed ID: 33765478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of bleeding in patients using antithrombotic agents: prediction, prevention, protection and problem-oriented intervention.
    Scharf RE
    Hamostaseologie; 2009 Nov; 29(4):388-98. PubMed ID: 19882082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Intracranial Hemorrhage in Ground-level Fall With Antiplatelet or Anticoagulant Agents.
    Ganetsky M; Lopez G; Coreanu T; Novack V; Horng S; Shapiro NI; Bauer KA
    Acad Emerg Med; 2017 Oct; 24(10):1258-1266. PubMed ID: 28475282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.
    Wise MR; Gill P; Lensen S; Thompson JM; Farquhar CM
    Am J Obstet Gynecol; 2016 Nov; 215(5):598.e1-598.e8. PubMed ID: 27287687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of abnormal uterine bleeding on anticoagulation: the patient-clinician perspective.
    Samuelson Bannow BT
    J Thromb Haemost; 2024 Jul; 22(7):1819-1825. PubMed ID: 38642705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of abnormal uterine bleeding in women with mechanical heart valve prosthesis and anticoagulant therapy.
    Saha PK; Rakshit BM; Jana N; Dutta S; Roy SB; Sengupta G
    J Indian Med Assoc; 2011 Dec; 109(12):908-11. PubMed ID: 23469574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Menorrhagia during oral anticoagulant therapy].
    Hellfritzsch M; Hvas AM; Dueholm M; Grove EL; Würtz M
    Ugeskr Laeger; 2020 Nov; 182(49):. PubMed ID: 33280643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding risk of combined oral anticoagulant and antiplatelet therapy in cardiovascular disease.
    Verheugt FW
    J Cardiovasc Risk; 1996 Apr; 3(2):229-32. PubMed ID: 8836868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal Agents for Oral Antiplatelet and Anticoagulant Treatment During Bleeding Events: Current Strategies.
    Raimondi P; Hylek EM; Aronis KN
    Curr Pharm Des; 2017; 23(9):1406-1423. PubMed ID: 27917717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of new oral anticoagulants with dual antiplatelet therapy in patients with acute coronary syndromes.
    Tsu LV; Dager WE
    Ann Pharmacother; 2013 Apr; 47(4):573-7. PubMed ID: 23548645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.